Clinical Trials Directory

Trials / Completed

CompletedNCT06787547

Effectiveness and Safety of a Novel Intravascular Lithotripsy System in Severely Calcified Coronary Lesions(COCALP)

A Prospective, Multi-center, Single-arm, Objective Performance Goal Pre-specified Study to Evaluate the Safety and Effectiveness of Intravascular Lithotripsy Generator Combined with SONICO-CX Coronary Intravascular Lithotripsy (IVL) Catheter for Pre-treatment of Coronary Calcification Before Stent Implantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
266 (actual)
Sponsor
Spectrumedics Medical Technology(Shanghai)Co.,Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective, multicenter, single-arm trial designed to investigate the effectiveness and safety of this intravascular lithotripsy system to treat severely calcified coronary lesions before stenting.

Detailed description

Subject Population: Subjects ≥ 18 years of age with de novo, calcified coronary artery lesions presenting with stable, unstable or silent ischemia that are suitable for percutaneous coronary intervention (PCI). 266 subjects at 11 sites will be enrolled.Subjects will be followed through discharge, 30 days, 6months.

Conditions

Interventions

TypeNameDescription
DEVICEIVL(Sonico-CX)SONICO-CX® balloon matched 1:1 to the reference vessel diameter, was advanced to the target lesion to pretreat

Timeline

Start date
2021-12-01
Primary completion
2022-11-29
Completion
2023-05-31
First posted
2025-01-22
Last updated
2025-01-22

Locations

11 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06787547. Inclusion in this directory is not an endorsement.